REFERENCES
- Litovitz TL, Klein-Schwartz W, White S, Cobaugh DJ, Youniss J, Omslaer JC, Drab A, Benson BE. 2000 Annual report on the American Association Of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med 2001; 19(5)337–395
- Parrish HM, Khan MS. Bites by Coral Snakes: report of 11 representative cases. Am J Med Sci. 1967; 253: 561–568
- Norris R, Dart RC. Apparent coral snake envenomation in a patient without visible fang marks. Am J Emerg Med 1989; 7(4)402–405
- , ESI Lederle (Wyeth-Ayerst) product discontinuation notice. 1/30/01.
- Vital-Brazil O. Coral snake venoms: mode of action and pathophysiology of experimental envenomation. Rev Inst Med Trop Sao Paulo 1987; 29(3)119–126
- Arroyo O, Rosso JP, Vargas O, Gutierrez JM, Cerdas L. Skeletal muscle necrosis induced by phospholipase A2 isolated from the venom of coral snake Micrurus nigrocintus nigrocintus. Comp Biochem Physiol B 1987; 87(4)949–952
- , Wyeth Antivenin (Micrurus fulvius)-product information. 1983.
- Kitchens C, Van Mierop L. Envenomation by the eastern coral snake (Micrurus fulvius fulvius). J Am Med Assoc 1987; 258(12)1615–1618
- Minton SA. Paraspecific protection by elapid and sea snake antivenins. Toxicon 1967; 5: 47–55
- Meier J, Theakston RDG. Approximate LD50 determinations of snake venoms using eight to ten experimental animals. Toxicon 1986; 24(4)395–401
- Bolanos R, Cerdas L, Taylor R. The production and characteristics of a coral snake (Micrurus mipartitus hertwigi) antivenin. Toxicon 1975; 13: 139–142